Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level.

Male-Specific Transcription Factor Occupancy Alone Does Not Account for Differential Methylation at Imprinted Genes in the mouse Germ Cell Lineage. G3 (Bethesda) (2016) 0.75

Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family. Cell Death Differ (2016) 0.75

Damage limitation. Elife (2016) 0.75

Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerization. Cell Death Differ (2016) 0.75

Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science (1996) 19.48

Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys J (1999) 13.18

The PredictProtein server. Nucleic Acids Res (2004) 10.89

The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc (2015) 8.53

A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell (1993) 8.26

Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell (1999) 4.87

p63 protects the female germ line during meiotic arrest. Nature (2006) 3.98

Drosophila p53 binds a damage response element at the reaper locus. Cell (2000) 3.92

Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci U S A (1997) 3.57

Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell (2000) 3.41

Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance. Science (2001) 3.16

Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum Mol Genet (2001) 2.95

The p53 family: guardians of maternal reproduction. Nat Rev Mol Cell Biol (2011) 2.13

Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med (2009) 2.03

Distinct DNA-damage-dependent and -independent responses drive the loss of oocytes in recombination-defective mouse mutants. Proc Natl Acad Sci U S A (2005) 2.03

Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data. Nat Biotechnol (2009) 1.78

Unfolded conformations of alpha-lytic protease are more stable than its native state. Nature (1998) 1.75

Commuting the death sentence: how oocytes strive to survive. Nat Rev Mol Cell Biol (2001) 1.74

A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol Cell Biol (2002) 1.73

Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol Cancer Ther (2004) 1.72

Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers. Implications on the dominant negative effect. J Biol Chem (2002) 1.44

p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction (2008) 1.41

Structural evolution of C-terminal domains in the p53 family. EMBO J (2007) 1.32

DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. Mol Cell (2012) 1.27

DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramer. Cell (2011) 1.25

Conformational stability and activity of p73 require a second helix in the tetramerization domain. Cell Death Differ (2009) 1.22

Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway. Science (2014) 1.21

Conservation of DNA-binding specificity and oligomerisation properties within the p53 family. BMC Genomics (2009) 1.16

High throughput production of recombinant human proteins for crystallography. Methods Mol Biol (2008) 1.08

The C-terminus of p63 contains multiple regulatory elements with different functions. Cell Death Dis (2010) 1.07

DNA-binding and transactivation activities are essential for TAp63 protein degradation. Mol Cell Biol (2005) 1.04

Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC). Am J Med Genet A (2009) 1.02

High thermostability and lack of cooperative DNA binding distinguish the p63 core domain from the homologous tumor suppressor p53. J Biol Chem (2001) 1.01

Structures of p63 DNA binding domain in complexes with half-site and with spacer-containing full response elements. Proc Natl Acad Sci U S A (2011) 0.97

Analysis of the oligomeric state and transactivation potential of TAp73α. Cell Death Differ (2013) 0.94

Metastable states and folding free energy barriers. Nat Struct Biol (1998) 0.93

Order and disorder control the functional rearrangement of influenza hemagglutinin. Proc Natl Acad Sci U S A (2014) 0.86

Structural basis of p63α SAM domain mutants involved in AEC syndrome. FEBS J (2011) 0.84

Ionizing radiation-induced TAp63α phosphorylation at C-terminal S/TQ motifs requires the N-terminal transactivation (TA) domain. Cell Cycle (2011) 0.79

Gene regulatory mechanisms orchestrated by p63 in epithelial development and related disorders. Biochim Biophys Acta (2015) 0.79

Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis. Mol Ther (2014) 0.85

Analyzing native membrane protein assembly in nanodiscs by combined non-covalent mass spectrometry and synthetic biology. Elife (2017) 0.84

Control mechanisms in germ cells mediated by p53 family proteins. J Cell Sci (2017) 0.75

Acceleration of protein backbone NMR assignment by combinatorial labeling: Application to a small molecule binding study. Biopolymers (2016) 0.75

Cell cycle arrest in mitosis promotes interferon-induced necroptosis. Cell Death Differ (2019) 0.75